Home » Moderna Teams Up with Metagenomi for CRISPR Research
Moderna Teams Up with Metagenomi for CRISPR Research
Moderna has partnered with gene-editing biotech Metagenomi to develop therapeutics for patients with serious genetic diseases.
Under the multiyear collaboration, the companies will leverage Metagenomi’s CRISPR and other gene editing-based platforms and Moderna’s messenger RNA-based and nanoparticle delivery technologies.
Metagenomi will receive an undisclosed upfront payment, along with an equity investment, research funding and milestones-based payments for unspecified disease targets.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May